-
Feedback received
We would like to thank everyone who took the trouble to feedback on their experience of our digital health partnerships event, whether via our online feedback form, social media posts or email. All are appreciated and will help us shape future events. A selection of the comments we received are…
-
Autonomous telemedicine assistant helps increase clinical capacity
Ufonia, an innovative Oxford-based digital health company, has built Dora – an autonomous telemedicine assistant – for use in routine clinical conversations. As an alternative to hospital visits where clinically appropriate, it increases clinical capacity, reduces provider costs, improves patient convenience and eases demand on healthcare staff. Dora is accessible…
-
Digital tool improves pre-surgery experience and improves efficiency
After the onset of Covid-19 pandemic many non-urgent elective activities were postponed to free up inpatient and critical care capacity. The Nuffield Orthopaedic Centre (NOC) faced a challenge in increasing its elective capacity and reducing the backlog which built up during the pandemic. In addition, insufficient patients were ‘fit for…
-
AI tool supports clinical decision-making in stroke care
Health Innovation Oxford & Thames Valley (HIOTV) has played a key role in the first AI solution adopted at scale by an NHS medical service. We have been working with Integrated Stroke Delivery Networks (ISDNs) across England to roll out and evaluate brain imaging technology which incorporates artificial intelligence (AI)…
-
First digital therapeutic adopted in the NHS supports better sleep
Insomnia affects one in ten adults. Poor sleep has a negative impact on physical and mental health, performance, and safety. Health Innovation Oxford & Thames Valley (HIOTV) led the first large-scale NHS rollout of direct access digital medicine in partnership with Big Health, the company behind Sleepio, an evidence-based digital…
-
AI-enabled epilepsy diagnostic could bring many benefits
Epilepsy is a common neurological disorder characterised by recurring, unprovoked seizures. There is no definitive diagnostic test and waits for diagnosis can be long. Earlier diagnosis allows for quicker initiation of treatment and reduces the risk of hospital admissions. Nelli® is a remote monitoring device that allows patients to be…
-
Evaluation focuses on new digital therapeutic for depression
Depression is one of the most prevalent mental health disorders, affecting around one in six adults in the UK. Current treatments include a combination of self-help, talking therapies and medication, as well as digital therapeutics. These are software-based therapies that have undergone clinical trials and regulatory review. Cognitive behavioural therapy…
-
AI-enhanced tech identifies patients at risk of diabetes
Diabetes can be a chronic and lifelong condition, affecting quality of life for patients and significantly impacting NHS resources. Diabetes is associated with reduced life expectancy owing to a greater risk of heart disease, stroke, peripheral neuropathy, renal disease, blindness and amputation. The NHS currently spends at least £10 billion…
-
Home monitor uses AI to predict asthma risk in children
More than one million children in the UK currently receive treatment for asthma. The estimated financial burden of asthma on the NHS is at least £1.1 billion. Acute asthma attacks remain a leading cause of unplanned hospital admissions, emergency visits and missed schooldays. ‘Albus Home’ is a contactless automated bedside…
-
AI platform predicts risks relating to coronary artery disease
In the UK, 2.3 million people are living with coronary artery disease (CAD) which accounts for an estimated 66,000 deaths every year. Earlier identification of patients with CAD could facilitate the deployment of risk factor modifying therapies which in turn could reduce rates of morbidity and mortality. CaRi-Heart® is medical…
-
Neuroimaging analysis tools support dementia diagnosis
Almost one million people in the UK live with dementia, with an associated economic cost estimated at £25 billion in 2021. FSL-clinical is a comprehensive library of analysis tools for neuroimaging developed by scientists at the Wellcome Centre for Integrative Neuroimaging (WIN), into a user-friendly platform for routine clinical use.
-
Novel AI technology shows potential in liver disease and other conditions
Primary sclerosing cholangitis (PSC) is an uncommon chronic liver disease which affects approximately seven people in every 100,000 in the UK. Accurate diagnosis is critical to ensure patients with rare hepatobiliary diseases such as PSC receive the right care and avoid invasive and expensive alternative investigations. There is currently no…
-
AI insights aid prostate cancer symptom tracking, monitoring and management
Prostate cancer is the most common cancer in men with about 1,000 new cases diagnosed every week in the UK. Support for men post diagnosis can involve managing side-effects (physical, sexual, emotional) which may be life-long and affect quality of life. Wave Health Pro is a digital application which allows…
-
New device supports earlier diagnosis of chronic respiratory disease
Chronic Obstructive Pulmonary Disease (COPD) is a lung condition characterised by chronic respiratory symptoms that cause persistent, often progressive, airflow obstruction. Approximately 1.4 million people in England aged 40 or over have a COPD diagnosis with a further 500,000 undiagnosed. N-Tidal is a point-of-care diagnostic medical device that can be…
-
Poster: Wave Health digital health app for managing prostate cancer
Download poster PDF: Wave Health
-
Poster: PocDoc – healthy heart checks save lives
Download poster PDF: PocDoc Poster
-
Poster: Using AI to reduce non-attendance at outpatient clinics
Download poster PDF: DNA AI APP
-
Poster: my mhealth – digitally enhanced pulmonary rehabilitation
Download poster PDF: my mhealth